HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-Piperazinecarboxamide → (rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid amide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-Piperazinecarboxamide | HCID 258192 | — |
| Reactant | (Rac)-6-[1-(6-chloro-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-5,7-difluoro-quinoline | HCID 58147541 | — |
| Product | (rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid amide | HCID 50914628 | — |
Reaction Steps
The title compound was prepared in analogy to Example 3 using (rac)-6-[1-(6-chloro-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-5,7-difluoro-quinoline (Intermediate C) and piperazine-1-carboxamide instead of piperazin-2-one (tR 3.16 min (conditions 1), MH+=438, 1H-NMR in DMSO-d6: 8.95 (d, 1H); 8.46 (d, 1H); 7.80 (d, 1H); 7.65 (d, 1H); 7.61 (s, 1H); 7.60 (m, 1H); 7.08 (d, 1H); 6.07 (s, 2H); 4.98 (m, 1H); 3.15-3.40 (m, 8H); 1.88 (d, 3H)).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08389526B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-0e6d8ade794447ad8826fe57fb0d7f87 |
| Source note | uspto-grants-2013_03 |